# clm_B9E0E558C863

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: total_equity  
value: 31,711,400,000 United States dollar  
valid_from: 2026-06-30  
valid_to: 2026-09-30  
published: 2026-07-30  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_24A29A7153C0  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals total equity: 31,711,400,000 United States dollar", as of 2026-06-30 (until 2026-09-30). Claim clm_B9E0E558C863, https://asof.is/claim/clm_B9E0E558C863, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000087258926000025/0000872589-26-000025-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q2 FY2026, filed 2026-07-30  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000087258926000025/0000872589-26-000025-index.htm (primary, SEC EDGAR 10-Q Q2 FY2026, published 2026-07-30)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 31,423,600,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_B9E0E558C863](/claim/clm_B9E0E558C863.md) | [clm_98A5851FED3C](/claim/clm_98A5851FED3C.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.